GLP-1 drugs are gaining popularity as an innovative solution to weight loss. With almost 43% of the US population being obese, this presents a strategic opportunity for the healthcare industry. Only 20% of Semaglutide users experience side effects, and the significant advertising spending by Rx manufacturers is driving demand for this new class of weight loss drugs.

In episode 48 of Kantar's Retail Sound Bites, hosts Barry Thomas, senior retail thought leader, and Rachel Dalton, head of retail insights, discuss GLP-1 medications and their influence on the retail landscape with nurse practitioners Leslie Thomas and Cathy Watkins lead the Signature Image Medical Spa in Atlanta, GA.

Have a topic you’d like us to cover? Contact us at Kantar’s Retail Sound Bites Podcast.

Barry's contact information:
[email protected]
Barry's LinkedIn

Rachel's contact information:
[email protected]
Rachel's LinkedIn

https://www.signatureimageatlanta.com/

OpenAI’s new GPTs now let uses create custom versions of ChatGPT  www.openai.com

Viral streamer partners with Kellogg’s veteran to launch BFY snack company https://www.usatoday.com/story/money/food/2023/11/13/twitch-streamer-pokimane-launches-myna-snacks/71136108007/

​Pizza Hut’s ‘Your Mood, Your Pizza’ campaign uses AI to suggest items  www.dominos.com

https://www.wsj.com/business/ozempic-impact-snack-food-companies-9eec87e5?mod=retail_more_article_pos45

https://www.cnn.com/2023/11/13/business/self-checkout-stores-shopping/index.html

https://www.cnbc.com/2023/11/10/amazon-top-fresh-exec-says-store-reopenings-part-of-grocery-revamp.html